leisure time -WSS

leisure time

author：fashion 2025-10-01 11:00:15 - browse：366

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： As H5N1 spreads in cows, experts warn against drinking raw milk

leisure time

WSS

Ripples from Flovent's discontinuation is killing children with asthma

WuXi Biologics beefs up its lobbying operation

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

STAT series 'Denied by AI' wins major journalism prizes

Louisiana bill approved classifying abortion pills as controlled substances

Oak Street deal isn't the answer to health care's woes

focus

leisure time

knowledge

In age of alternative facts, a scholarly course on calling out crap

The White House hikes tariffs on plastic syringes made in China

In Memoriam: Notable people who died in 2023

Novo Nordisk testing Wegovy against alcohol

After affirmative action ruling, medical educators look to 'holistic review'

Hospitals need to get ahead of regulations on climate change

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why we need mandatory labeling of GMO products

Jerome Adams on the need for new antivirals for Covid

Bird flu makes raw milk dangerous to consume, mouse study finds

entertainment

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Galapagos to make CAR

Obesity drug from Roche shows promise in early study

Novo Nordisk testing Wegovy against alcohol

New research sheds light on how often breast cancer is overdiagnosed

Guardant Health colon cancer test endorsed by FDA advisory panel

hotspot

entertainment

leisure time

focus